======= STARD13 ======= == Gene Information == * **Official Symbol**: STARD13 * **Official Name**: StAR related lipid transfer domain containing 13 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=90627|90627]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9Y3M8|Q9Y3M8]] * **Interactions**: [[https://thebiogrid.org/search.php?search=STARD13&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20STARD13|Open PubMed]] * **OMIM**: [[https://omim.org/entry/609866|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a protein which contains an N-terminal sterile alpha motif (SAM) for protein-protein interactions, followed by an ATP/GTP-binding motif, a GTPase-activating protein (GAP) domain, and a C-terminal STAR-related lipid transfer (START) domain. It may be involved in regulation of cytoskeletal reorganization, cell proliferation, and cell motility, and acts as a tumor suppressor in hepatoma cells. The gene is located in a region of chromosome 13 that is associated with loss of heterozygosity in hepatocellular carcinomas. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Aug 2011]. * **UniProt Summary**: N/A |START| |RhoGAP| |endothelial tube lumen extension| |morphogenesis of an endothelium| |endothelial tube morphogenesis| |negative regulation of cell migration involved in sprouting angiogenesis| |negative regulation of sprouting angiogenesis| |negative regulation of blood vessel endothelial cell migration| |regulation of cell migration involved in sprouting angiogenesis| |negative regulation of endothelial cell migration| |endothelial cell migration| |negative regulation of epithelial cell migration| |regulation of sprouting angiogenesis| |lipid droplet| |epithelial cell migration| |epithelium migration| |regulation of blood vessel endothelial cell migration| |tissue migration| |endothelium development| |mitochondrial membrane| |negative regulation of angiogenesis| |negative regulation of blood vessel morphogenesis| |negative regulation of vasculature development| |lipid binding| |regulation of endothelial cell migration| |ameboidal-type cell migration| |regulation of epithelial cell migration| |negative regulation of cell migration| |negative regulation of cell motility| |GTPase activator activity| |regulation of angiogenesis| |epithelial tube morphogenesis| |negative regulation of cellular component movement| |regulation of vasculature development| |negative regulation of locomotion| |regulation of small GTPase mediated signal transduction| |positive regulation of GTPase activity| |morphogenesis of an epithelium| |regulation of GTPase activity| |tissue morphogenesis| |tube morphogenesis| |positive regulation of hydrolase activity| |tube development| |regulation of cell migration| |regulation of cell motility| |negative regulation of developmental process| |cell migration| |regulation of locomotion| |regulation of cellular component movement| |regulation of anatomical structure morphogenesis| |cell motility| |localization of cell| |epithelium development| |negative regulation of multicellular organismal process| |regulation of hydrolase activity| |locomotion| |positive regulation of catalytic activity| |movement of cell or subcellular component| |tissue development| |positive regulation of molecular function| |regulation of intracellular signal transduction| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp102|Nifuroxazide 5μM R03 exp102]]|-1.86| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 13371 * **Expression level (log2 read counts)**: 2.92 {{:chemogenomics:nalm6 dist.png?nolink |}}